Tribe Public’s CEO Webinar Presentation and Q&A Event titled “Enabling Continuous Drug Delivery for Parkinson’s Disease & Beyond” was held Wednesday, December 18 (8:30am PT / 11:30 am ET). Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER) Chief Executive Officer, Steven A. Ledger, delivered a presentation titled “Enabling Continuous Drug Delivery for Parkinson’s Disease & Beyond” and was available for a Q&A session at the end of the presentation.
Serina is a clinical-stage biotechnology company developing a pipeline of wholly owned drug product candidates to treat neurological diseases and other indications. Serina’s POZ Platform™ provides the potential to improve the integrated efficacy and safety profile of multiple modalities including small molecules, RNA-based therapeutics and antibody-based drug conjugates (ADCs). Serina is headquartered in Huntsville, Alabama on the campus of the HudsonAlpha Institute of Biotechnology. For more information, please visit https://serinatherapeutics.com. Join the Tribe at future events by signing up today at www.TribePublic.com View Disclaimer: https://tribepublic.com/disclaimers.
